Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NORTHVALE, N.J., June 10, 2013 (GLOBE NEWSWIRE) -- Elite Laboratories, a wholly owned subsidiary of Elite Pharmaceuticals, Inc. (collectively ""Elite” or the “Company”) (OTCBB:ELTP) today announced that the Company submitted a Citizen Petition to the U.S. Food and Drug Administration (the “FDA”) requesting that the FDA make a determination that (a) it is suitable to use the currently approved and marketed ANDA product (ANDA 078648, generic to Drixoral brand) as the Reference Listed Drug (“RLD”) since the current RLD Drixoral brand is no longer available in the marketplace, and (b) that this currently approved and marketed ANDA product is suitable to use as a RLD for an equivalent active ingredient comprised of a difference salt.
Help employers find you! Check out all the jobs and post your resume.
